Research Article

C-Peptide Versus Insulin: Relationships with Risk Biomarkers of Cardiovascular Disease in Metabolic Syndrome in Young Arab Females

Table 1

Baseline characteristics of normal-weight (Group I ( )) versus overweight/obese females (Group II ( )).

VariablesGroup I mean (SD)Group II mean (SD)Percentage difference (%) value

Body mass index (kg/m2)21.4 (2.5)30.8 (4.5)30.5<0.001
Waist circumference (cm)66.9 (5.2)83.7 (10.3)20.1<0.001
C-peptide (ng/mL)2.1 (0.7)2.5 (0.7)14.70.02
hs-C-reactive protein (mg/L)2.6 (5.3)5.3 (5.7)51.40.03
Diastolic blood pressure (mmHg)68 (9.7)73 (10.4)6.80.03
Systolic blood pressure (mmHg)109.8 (9.8)115 (9.3)4.50.02
Fasting blood glucose (mmol/mL)4.4 (0.3)4.5 (0.3)2.00.25
Fasting insulin (μU/mL)6.5 (3.8)10.6 (6.0)38<0.001
HbA1c (%)3.9 (0.4)4.1 (0.4)40.08
Total cholesterol (mg/dL)150 (26.7)156 (20.9)3.90.28
Triglyceride (mg/dL)64.1 (24.8)73.1 (27.8)12.30.13
HDL-C* (mg/dL)63.1 (13.6)56.1 (10.1)−12.40.01
LDL** (mg/dL)75.6 (22.2)83.5 (20.8)9.40.11
Uric acid (mg/dL)3.3 (0.7)4.1 (0.9)18.9<0.001
Leptin (ng/mL)20.3 (9.7)37.7 (14.8)46.2<0.001
Adiponectin (μg/mL)13.4 (1.4)13.0 (1.1)−2.50.27
HOMA-IR1.3 (0.8)2.1 (1.3)39.8<0.001

*High-density lipoprotein cholesterol, **low-density lipoprotein cholesterol.